A laboratory technician carries a cryogenic container of blood to be treated before genetically modifying a patient’s immune cells in the laboratory. March 8, 2019, at a production laboratory unit of the Paoli-Calmettes Institute in France. GERARD JULIEN/AFP via Getty Images On February 28, 2022, the Food and Drug Administration (FDA) approved ciltacabtagene autoleucel (cilta-cel)...
